Skip to main content

Table 7 Patient satisfaction with study pen device, n (%)

From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)

Characteristic

Ovaleap® (n = 151)

Gonal-f® (n = 142)

Confidence about accurate dose

  

 Very confident

123 (81.5)

112 (78.9)

 Confident

28 (18.5)

30 (21.1)

Confidence about correct injection

  

 Very confident

115 (76.2)

110 (77.5)

 Confident

34 (22.5)

32 (22.5)

 Not confident

1 (0.7)

0 (0)

Plainness of instructional text

  

 Very easy

113 (74.8)

100 (70.4)

 Easy

38 (25.2)

42 (29.6)

Frequency of need for explanation of administration

  

 Never

85 (56.3)

67 (47.2)

 Once

57 (37.7)

69 (48.6)

 Twice

7 (4.6)

2 (1.4)

 Three times

0 (0)

1 (0.7)

Convenience of pen usage

  

 Very convenient

117 (77.5)

107 (75.4)

 Convenient

34 (22.5)

35 (24.6)

Satisfaction with administration

  

 Very satisfied

116 (76.8)

108 (76.1)

 Satisfied

35 (23.2)

34 (23.9)